-
1
-
-
50549097782
-
The new tumor suppressor genes ING: Genomic structure and status in cancer
-
Ythier D, Larrieu D, Brambilla C, et al. The new tumor suppressor genes ING: genomic structure and status in cancer. Int J Cancer, 2008, 123 (7): 1483-1490.
-
(2008)
Int J Cancer
, vol.123
, Issue.7
, pp. 1483-1490
-
-
Ythier, D.1
Larrieu, D.2
Brambilla, C.3
-
2
-
-
67650635385
-
ING family of tumor suppressors
-
Kutateladze TG. ING family of tumor suppressors. Curr Drug Targets, 2009, 10 (5): 384.
-
(2009)
Curr Drug Targets
, vol.10
, Issue.5
, pp. 384
-
-
Kutateladze, T.G.1
-
3
-
-
35548939802
-
After a decade of study-ING, a PHD for a versatile family of proteins
-
DOI 10.1016/j.tibs.2007.08.006, PII S0968000407002289
-
Soliman MA, Riabowol K. After a decade of study-ING, a PHD for a versatile family of proteins. Trends Biochem Sci, 2007, 32 (11): 509-519. (Pubitemid 350008066)
-
(2007)
Trends in Biochemical Sciences
, vol.32
, Issue.11
, pp. 509-519
-
-
Soliman, M.A.1
Riabowol, K.2
-
4
-
-
58149171661
-
The ING gene family in the regulation of cell growth and tumorigenesis
-
Coles AH, Jones SN. The ING gene family in the regulation of cell growth and tumorigenesis. J Cell Physiol, 2009, 218 (1): 45-57.
-
(2009)
J Cell Physiol
, vol.218
, Issue.1
, pp. 45-57
-
-
Coles, A.H.1
Jones, S.N.2
-
5
-
-
14644423310
-
Function of the ING family of PHD proteins in cancer
-
Gong W, Suzuki K, Russell M, et al. Function of the ING family of PHD proteins in cancer. Int J Biochem Cell Biol, 2005, 37 (5): 1054-1065.
-
(2005)
Int J Biochem Cell Biol
, vol.37
, Issue.5
, pp. 1054-1065
-
-
Gong, W.1
Suzuki, K.2
Russell, M.3
-
6
-
-
0038520190
-
p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity
-
Shiseki M, Nagashima M, Pedeux RM, et al. p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res, 2003, 63 (10): 2373-2378. (Pubitemid 36605171)
-
(2003)
Cancer Research
, vol.63
, Issue.10
, pp. 2373-2378
-
-
Shiseki, M.1
Nagashima, M.2
Pedeux, R.M.3
Kitahama-Shiseki, M.4
Miura, K.5
Okamura, S.6
Onogi, H.7
Higashimoto, Y.8
Appella, E.9
Yokota, J.10
Harris, C.C.11
-
7
-
-
67449088207
-
Reviewing the current classification of inhibitor of growth family proteins
-
Unoki M, Kumamoto K, Takenoshita S, et al. Reviewing the current classification of inhibitor of growth family proteins. Cancer Sci, 2009, 100 (7): 1173-1179.
-
(2009)
Cancer Sci
, vol.100
, Issue.7
, pp. 1173-1179
-
-
Unoki, M.1
Kumamoto, K.2
Takenoshita, S.3
-
8
-
-
0036922548
-
ING1 in hepatocellular carcinoma: Relationships to tumour differentiation and cyclin E kinase activity
-
DOI 10.1080/003655202762671332
-
Ohgi T, Masaki T, Nakai S, et al. Expression of p33 (ING1) in hepatocellular carcinoma: relationships to tumour differentiation and cyclin E kinase activity. Scand J Gastroenterol, 2002, 37 (12): 1440-1448. (Pubitemid 36051506)
-
(2002)
Scandinavian Journal of Gastroenterology
, vol.37
, Issue.12
, pp. 1440-1448
-
-
Ohgi, T.1
Masaki, T.2
Nakai, S.3
Morishita, A.4
Yukimasa, S.5
Nagai, M.6
Miyauchi, Y.7
Funaki, T.8
Kurokohchi, K.9
Watanabe, S.10
Kuriyama, S.11
-
9
-
-
61949382002
-
Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner
-
Zhu Z, Luo Z, Li Y, et al. Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner. Hepatology, 2009, 49 (2): 504-512.
-
(2009)
Hepatology
, vol.49
, Issue.2
, pp. 504-512
-
-
Zhu, Z.1
Luo, Z.2
Li, Y.3
-
10
-
-
39149143675
-
Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma
-
Zhang HK, Pan K, Wang H, et al. Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma. Cancer Lett, 2008, 261 (2): 183-192.
-
(2008)
Cancer Lett
, vol.261
, Issue.2
, pp. 183-192
-
-
Zhang, H.K.1
Pan, K.2
Wang, H.3
-
11
-
-
60549094969
-
Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma
-
Fang F, Luo LB, Tao YM, et al. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev, 2009, 18 (2): 409-416.
-
(2009)
Cancer Epidemiol Biomarkers Prev
, vol.18
, Issue.2
, pp. 409-416
-
-
Fang, F.1
Luo, L.B.2
Tao, Y.M.3
|